Skip to main content
Fig. 6 | EJNMMI Radiopharmacy and Chemistry

Fig. 6

From: Preclinical evaluation of new GRPR-antagonists with improved metabolic stability for radiotheranostic use in oncology

Fig. 6

a Comparison of biodistribution results at 4 h pi across [111In]In-AU-SAR-M1 (blue bars), [111In]In-AU-SAR-M2 (red bars) and [111In]In-AU-SAR-M3 (green bars) (from left to right), presented as average %IA/g ± sd (error bars), n = 4. Results for gastrointestinal tract (GI) and carcass are presented as average %IA ± sd.** = p < 0.01; *** = p < 0.001; and **** = p < 0.0001; b T/O ratios for across [111In]In-AU-SAR-M1 (blue bars), [111In]In-AU-SAR-M2 (red bars) and [111In]In-AU-SAR-M3 (green bars) at 4 h pi

Back to article page